Early initiation of sodium–glucose co-transporter-2 inhibitors in heart failure patients: a nationwide study
In this nationwide study, SGLT-2i initiation increased over the years but remains suboptimal and highly variable across hospitals and patient phenotypes, highlighting opportunities to improve GDMT.
Authors
- Margaux Lafaurie (ORCID: https://orcid.org/0000-0001-6010-2891)
- Frédéric Bouisset (ORCID: https://orcid.org/0000-0001-8642-0273)
- François Montastruc (ORCID: https://orcid.org/0000-0001-7056-8126)
- Miloud Cherbi (ORCID: https://orcid.org/0009-0004-8952-6283)
- Clément Delmas (ORCID: https://orcid.org/0000-0001-9180-9128)
- Thibault Lhermusier (ORCID: https://orcid.org/0000-0002-4260-2339)
- Paul Gautier (ORCID: https://orcid.org/0009-0008-9934-8432)
- Meyer Elbaz
Institutions
- Inserm (FR)
- Université Fédérale de Toulouse Midi-Pyrénées (FR)
- Pharmacochimie et Biologie pour le Développement (FR)
Publication Details
- Journal
- ESC Heart Failure
- Published
- 2026-01-08
- DOI
- https://doi.org/10.1093/eschf/xvaf009
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00